ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy
Publication
, Conference
Riedel, RF; Chawla, SP; Druta, M; Jones, RL; Schuetze, S; Lam, J; Zhuang, D; Freddo, JL; Adams, BJ; Theuer, CP; D'Angelo, SP
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Riedel, R. F., Chawla, S. P., Druta, M., Jones, R. L., Schuetze, S., Lam, J., … D’Angelo, S. P. (2023). ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Riedel, Richard F., Sant P. Chawla, Mihaela Druta, Robin Lewis Jones, Scott Schuetze, Joelle Lam, Dongliang Zhuang, et al. “ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Riedel RF, Chawla SP, Druta M, Jones RL, Schuetze S, Lam J, et al. ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Riedel, Richard F., et al. “ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Riedel RF, Chawla SP, Druta M, Jones RL, Schuetze S, Lam J, Zhuang D, Freddo JL, Adams BJ, Theuer CP, D’Angelo SP. ENVASARC: A pivotal trial of envafolimab and envafolimab in combination with ipilimumab in patients with advanced or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma who have progressed on prior chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences